Friday, December 9, 2016

Interpace Diagnostics Group (IDXG) and Johnson & Johnson (JNJ) extend buyout discussions through weekend at The Heldrich Hotel and Conference Center in New Brunswick predicts Sierra World Equity Review.

Interpace Diagnostics Group (IDXG) and Johnson & Johnson (JNJ) extend buyout discussions through weekend at The Heldrich Hotel and Conference Center in New Brunswick predicts Sierra World Equity Review. Shares of IDGX were sharply higher up 33% at the end of Friday's session. Sierra's colleague Natashsa has checked into the hotel for the weekend and will be working her sources to get the latest. Watch for breaking news, remember when it happens Sierra told you first!

Most of our publisher picks rise 100%, 200% or more once they hit the front page of our blog. Get some, sit back and enjoy the ride! 

**Our Latest Publisher Pick is  Pegasus Pharmaceuticals (PGUZ), the most undervalued biotech stock out there**

With over 1.5 million visitors to our blogs and thousands of visitors daily, Sierra World Equity Review will be giving MASSIVE MULTIPLE DAY targeted audience exposure to our latest Publisher Alert: Pegasus Pharmaceuticals (PGUZ)

Here is why our Publisher has initiated a  position in Pegasus Pharmaceuticals (PGUZ)

My NEW Pick is Pegasus Pharmaceuticals (PGUZ). It's cutting edge patented technology named the HeartVue™ 6S System allows for the non-invasive screening of heart disease. Incredibly the technology provides a 3d portrait of the heart in just 60 seconds. This is a huge game changer and the CEO has confirmed that they are now working with some big pharmaceutical companies,  2 are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY), both who have invested heavily in non-invasive screening for heart pathologies. With marketing already happening in Europe the company now has filed with the FDA for approval in the US. This stock is under the radar trading sub penny but that won't last long, the CEO has hinted at big news and stated he will be providing updates shortly, NOW is the time to buy before this tiny biotech gets discovered, they could become the biggest gainer of 2016!

My NEW Pick is a small biotech company called Pegasus Pharmaceuticals (PGUZ). They look like they could become the biggest gainer of the year, trading now in sub-penny range but likely to ink a partnership or even be acquired by one of the two big pharmaceutical company they are currently working with. Now is the time to buy shares of PGUZ, don't get left behind!

Pegasus Pharmaceuticals (PGUZ)  Highlights:

- An amazing share structure of just 21.6M O/S
- A float of just 5M
- Insiders own over half the float and they are NOT SELLING
-Patented game changing, revenue generating cutting edge technology that is desired by big Pharma
-CEO confirmed the company is working with some big Pharma's ( 2 of which are believed to be German based Bayer AG and US based Bristol Meyers-Squibb (BMY)
-Massive revenue potential, considering that in the US alone annually, approximately 635,000 Americans experience a new coronary event, 280,000 have a recurrent ischemic event, and an additional 150,000 have a silent first myocardial infarction. The ability to easily diagnosis heart disease will not only save countless lives but be incredibly lucrative, especially since the technology is patented by Pegasus Pharmaceuticals (PGUZ)

About Pegasus Pharmaceuticals (PGUZ)  

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies. The company offers HeartVue 6S System, which is a screening tool used to diagnose heart and other cardiac diseases. It serves cardiologists, general practitioners, physicians, intensive care units, hospitals, emergency rooms, clinics, fitness facilities, sports teams, and other emergency medical facilities


About Sierra

Hi, my name is Sierra and I'm 27 yrs old. I'm single and I live in Old Town in beautiful Key West, Florida. Thanks to a family inheritance I feel very blessed and fortunate to be financially independent allowing me to live life to the fullest!
Apart from the stock market my favorite things to do are mostly beach related, I love surfing and spend months of the year travelling to different surfing hot spots worldwide chasing the next big wave. When I'm not in the water you can find me playing beach volleyball, enjoying happy hour with friends or dancing the night away! 

Paddling out for the next wave!                                                                                 credit: juancap3q Tumblr

If you are in Key West stop by and say hi to me, if I'm not out of town it's likely I'll be at Sloppy Joes or The Schooner Wharf Bar once the sun goes down! I love to make new friends and men please do not be intimidated by my looks, I do not bite! Dance, be happy, enjoy life and good luck in all your trades!

Sierra World Equity Review

Independent and uncompensated! Sierra World Equity Review and it's publisher have never been compensated to promote any stock. We are not affiliated with any executives, owners, brokers, promoters or analysts. The publisher of Sierra World Equity Review is not a registered investment adviser, before making a purchase or sale of any securities featured on this site, we strongly recommend consultation with a registered securities representative. Please remember to do your own due diligence in regards to any stocks that appear on our websites, never trade securities based on Sierra's speculations or predictions! Please read our disclaimer and privacy policy below.